SCHEMBL19831002

SCHEMBL19831002

Cc1nc(C)c(C(=O)Nc2cccc(OC(C)C)c2)s1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.70
NPC1 O15118 5/20 0.70
SMN1; SMN2 Q16637 3/20 0.70
TP53 P04637 1/20 0.70
RECQL P46063 1/20 0.65
POLB P06746 1/20 0.63
MAPT P10636 6/20 0.55
CLK1 P49759 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.54
KMT2A Q03164 6/20 0.52
PKM P14618 1/20 0.52
F2 P00734 1/20 0.51
PLG P00747 1/20 0.51
PLAU P00749 1/20 0.51
PLAT P00750 1/20 0.51
KLKB1 P03952 1/20 0.51
PRSS1 P07477 1/20 0.51
KDM4E B2RXH2 2/20 0.50
CASP3 P42574 1/20 0.50
SENP8 Q96LD8 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23367925 0.84 RAB9A (0.72) RAB9ANPC1SMN1; SMN2TP53RECQL
SCHEMBL11651472 0.83 RAB9A (1.00) RAB9ANPC1SMN1; SMN2TP53RECQL
SCHEMBL23602 0.80 RAB9A (1.00) RAB9ANPC1SMN1; SMN2TP53RECQL
SCHEMBL27971290 0.78 RAB9A (0.70) RAB9ANPC1SMN1; SMN2TP53RECQL
SCHEMBL3587933 0.78 POLB (0.74) RAB9ANPC1SMN1; SMN2TP53POLB
SCHEMBL15096727 0.78 POLB (1.00) RAB9ANPC1SMN1; SMN2POLBMAPT
SCHEMBL2878844 0.77 RAB9A (0.69) RAB9ANPC1SMN1; SMN2TP53RECQL
SCHEMBL2883601 0.77 RAB9A (0.69) RAB9ANPC1SMN1; SMN2TP53RECQL
SCHEMBL2093226 0.76 CA2 (0.58) RAB9ANPC1SMN1; SMN2TP53MAPT
SCHEMBL13956819 0.76 RAB9A (0.56) RAB9ANPC1SMN1; SMN2TP53RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10315998-B2 Amide compound and the preparation method and use thereof SHENYANG SINOCHEM AGROCHEMICALS R&D CO., LTD. (CN) 2019-06-11 US disclosed
EP-3293179-A1 AMIDE COMPOUND AND THE PREPARATION METHOD AND USE THEREOF Shenyang Sinochem Agrochemicals R & D Co., Ltd. (CN) 2018-03-14 EP disclosed
US-20180029991-A1 AMIDE COMPOUND AND THE PREPARATION METHOD AND USE THEREOF Shenyang Sinochem Agrochemicals R&D Co., LTD (CN) 2018-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10315998-B2 Amide compound and the preparation method and use thereof CYP51A1, ERG28, NAT1 RAB9A 1568/4885NPC1 577/4885SMN1; SMN2 3374/4885
US-20180029991-A1 AMIDE COMPOUND AND THE PREPARATION METHOD AND USE THEREOF CYP51A1, ERG28, NAT1 RAB9A 1568/4885NPC1 577/4885SMN1; SMN2 3374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.